A Consensus Statement on the Use of Ketamine in the Treatment of Mood Disorders - Sanacora, G; Frye, MA; McDonald, W; American Psychiatric Association (APA) Council of Research Task Force on Novel Biomarkers and Treatments (JAMA Psychiatry, 2017)
et al.